Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ikuo Kushida
Observed name:
Ikuo KUSHIDA
Institution:
Eisai (Japan)
Observed institutions:
Nagoya City University,
Eisai (Japan)
OpenAlex ID:
A5032270438
Inhibition of Crystal Nucleation and Growth by Water-Soluble Polymers and its Impact on the Supersaturation Profiles of Amorphous Drugs
2013
·
Shunsuke Ozaki
, Ikuo Kushida
, et al.
·
Journal of Pharmaceutical Sciences
·
104
Supersaturation–Nucleation Behavior of Poorly Soluble Drugs and its Impact on the Oral Absorption of Drugs in Thermodynamically High-Energy Forms
2011
·
Shunsuke Ozaki
, Takuma Minamisono
, et al.
·
Journal of Pharmaceutical Sciences
·
88
Solvent shift method for anti-precipitant screening of poorly soluble drugs using biorelevant medium and dimethyl sulfoxide
2011
·
Taro Yamashita
, Shunsuke Ozaki
, et al.
·
International Journal of Pharmaceutics
·
77
E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2021
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
·
Cancer Research
·
76
Improvement of Dissolution and Oral Absorption of ER-34122, A Poorly Water-Soluble Dual 5-Lipoxygenase/Cyclooxygenase Inhibitor With Anti-Inflammatory Activity by Preparing Solid Dispersion
2002
·
Ikuo Kushida
, Masaki Ichikawa
, et al.
·
Journal of Pharmaceutical Sciences
·
76
Esterase-Like Activity of Human Serum Albumin. VIII. Reaction with Amino Acid p-Nitrophenyl Esters.
1992
·
Yukihisa KURONO
, Ikuo KUSHIDA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
50
PDF
Evaluation of Drug Supersaturation by Thermodynamic and Kinetic Approaches for the Prediction of Oral Absorbability in Amorphous Pharmaceuticals
2012
·
Shunsuke Ozaki
, Ikuo Kushida
, et al.
·
Journal of Pharmaceutical Sciences
·
36
Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists
2014
·
Yu Yoshida
, Taro Terauchi
, et al.
·
Bioorganic & Medicinal Chemistry
·
23
Solid State Characterization of E2101, A Novel Antispastic Drug
2002
·
Ikuo Kushida
, Kazuhide Ashizawa
·
Journal of Pharmaceutical Sciences
·
15
Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method
2012
·
Ikuo Kushida
, Masaharu Gotoda
·
Drug Development and Industrial Pharmacy
·
14
Reliable on-line sample preparation of basic compounds from plasma using a reversed phase restricted access media in column-switching LC
2006
·
Eiichi Yamamoto
, Hatsue Igarashi
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
7
Effective on-line purification for cationic compounds in rat bile using a column-switching LC technique
2005
·
Takahisa Sakaguchi
, Eiichi Yamamoto
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
6
Frozen water phase method for logD measurement using a 96-well plate
2011
·
Taro Yamashita
, Eiichi Yamamoto
, et al.
·
Talanta
·
5
Quantitative crystallinity determination for E1010, a novel carbapenem antibiotic, using differential scanning calorimetry
2011
·
Ikuo Kushida
·
Journal of Pharmacy and Pharmacology
·
4
The Measurement of cis-Platin and trans-Platin by Graphite Atomic Absorption Spectrophotometry.
1991
·
Ikuo KUSHIDA
, Ayumi TANAKA
, et al.
·
Chemical and Pharmaceutical Bulletin
·
1
PDF
Data from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Materials and Methods from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Table S2 from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Table S3 from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Tables from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Supplementary Figures from E7386, a Selective Inhibitor of the Interaction between β-Catenin and CBP, Exerts Antitumor Activity in Tumor Models with Activated Canonical Wnt Signaling
2023
·
Kazuhiko Yamada
, Yusaku Hori
, et al.
Corrigendum to “Design, synthesis, and structure–activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists” [Bioorg. Med. Chem. 22 (2014) 6071–6088]
2015
·
Yu Yoshida
, Taro Terauchi
, et al.
·
Bioorganic & Medicinal Chemistry
Crystal structure and dehydration behavior of E6070, a novel IKKβ protein kinase inhibitor for the treatment of rheumatoid arthritis
2013
·
Ikuo Kushida
·
Journal of Pharmaceutical and Biomedical Analysis
Screening of Physical Properties in Pharmaceutical Discovery
2001
·
Hiroshi ISHIHARA
, Yasushi ISHIHAMA
, et al.
·
Drug Metabolism and Pharmacokinetics
PDF
Show more works
View as search
Works count:
24
Citation count:
582
H-index:
10
I10-index:
10
Year
Topic
Type